pyrroles has been researched along with Congenital Errors of Steroid Metabolism in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, Y; Ferrand, AC; Gaudet, D; Ginsberg, HN; Gipe, D; Hanotin, C; Kereiakes, DJ; McKenney, JM; Roth, EM; Stein, EA | 1 |
1 trial(s) available for pyrroles and Congenital Errors of Steroid Metabolism
| Article | Year |
|---|---|
Effect of alirocumab, a monoclonal proprotein convertase subtilisin/kexin 9 antibody, on lipoprotein(a) concentrations (a pooled analysis of 150 mg every two weeks dosing from phase 2 trials).
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Atorvastatin; Cholic Acids; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoprotein(a); Male; Middle Aged; Nephelometry and Turbidimetry; Pyrroles; Steroid Metabolism, Inborn Errors; Subtilisin; Time Factors; Treatment Outcome | 2014 |